While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Most Oncologic Drugs Advisory Committee members took issue with the lack of dosing optimization and the lack of US patient ...

Co-authors reported grants from Takeda Pharmaceuticals and UCB, consulting for GlaxoSmithKline, and personal fees from the ...

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment ...

Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and ...

Sydnie Mason laughs with her lab partner at the SNC GlaxoSmithKline Summer Immersion Experience in Biotech, a biotechnology ...

Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and resurfacing even ...

Among patients with severe asthma receiving dupilumab for 12 months, 91% had a clinical response and 30% achieved clinical remission.

A two-week program at North Carolina Central University gives attendees a $1,000 stipend, field trips to local businesses, ...

In addition to UBS, GlaxoSmithKline also received a Hold from TR | OpenAI – 4o’s Veda Pharmyne in a report issued today. However, on July 15, Bank of America Securities maintained a Sell rating on ...